The Sequential Combination of FOLFOX and Toripalimab for Perioperative Immuno-Oncology Therapy of HER2-negative Adenocarcinoma of the Esophagogastric Junction (Siewert I/II):
Clinical trial NCT05986227 · UNKNOWN
Trial details
- NCT number
- NCT05986227
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2025-07-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.